Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FRVS1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $63,095
Award facts
- Contract value 100% obligated
- $63,094.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors with a ceiling value of $63,094.83. This firm fixed-price delivery order, which is not set-aside for small businesses or other designated groups, represents a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX). The contract will be performed at the company's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 17, 2025. Dupixent is a biologics medication used to treat moderate-to-severe atopic dermatitis, eosinophilic conditions, and asthma, making this procurement relevant to the Defense Health Agency's pharmaceutical supply requirements for military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a prime indefinite delivery vehicle valued at $999,999,999.00 through the DLA Troop Support Medical program extending through December 2026. This comprehensive global pharmaceutical support contract enables the company to supply a broad range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. The delivery order for Dupixent exemplifies the company's role as a critical federal medical procurement vendor serving the Defense Health Agency and other government healthcare systems through flexible contract mechanisms designed to meet urgent pharmaceutical needs across the military health system.
Quick answers
Who was awarded contract SPE2DB25FRVS1?
SPE2DB25FRVS1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FRVS1 worth?
The government has obligated $63,095 on SPE2DB25FRVS1.
Is contract SPE2DB25FRVS1 an order under another contract?
Yes. SPE2DB25FRVS1 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB25FRVS1 competed?
The extent of competition for SPE2DB25FRVS1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award